XRAY vs AZTA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

XRAY

50.2
AI Score
VS
AZTA Wins

AZTA

54.7
AI Score

Investment Advisor Scores

XRAY

50score
Recommendation
HOLD

AZTA

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XRAY AZTA Winner
Revenue 1.78B 454.62M XRAY
Net Income 27.00M -173.77M XRAY
Gross Margin 51.7% 43.6% XRAY
Net Margin 1.5% -38.2% XRAY
Operating Income 47.00M -177.21M XRAY
ROE 2.0% -11.5% XRAY
ROA 0.5% -9.3% XRAY
Total Assets 5.20B 1.88B XRAY
Cash 239.00M 189.65M XRAY
Current Ratio 1.63 2.50 AZTA

Relative Price Performance (Last 90 Days)

XRAY 1M: -2.9% · 3M: -26.5% AZTA 1M: +5.6% · 3M: +31.6%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.1 · Price: $9.50

AZTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.1% over 20 days), RSI 52

RSI (14): 51.6 · Price: $36.01

Fundamentals Snapshot

Metric XRAY AZTA
Market Cap — —
Forward P/E 6.4 65.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.1% 0.0%
EPS -2.73 -2.47
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, AZTA is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.